Magnetic resonance spectroscopy on hepatocellular carcinoma after transcatheter arterial chemoembolization
Du-Jun Bian, En-Hua Xiao, Dong-Xu Hu, Xiang-Yu Chen, Wei-Jun Situ, Shu-Wen Yuan, Jian-Ling Sun, Li-Ping Yang, Du-Jun Bian, En-Hua Xiao, Dong-Xu Hu, Xiang-Yu Chen, Wei-Jun Situ, Shu-Wen Yuan, Jian-Ling Sun, Li-Ping Yang
Abstract
Background and objective: Proton magnetic resonance spectroscopy (MRS) of the liver in vivo is in experimental phase. MRS observation on liver cancer after transcatheter arterial chemoembolization (TACE) has seldom been reported. This study was to investigate the value of MRS in assessing the metabolic changes of hepatocellular carcinoma (HCC) after TACE.
Methods: Twenty-five consecutive patients with pathologically-confirmed HCC received 1H MRS of all hepatic lesions using 1.5T whole body MR scanner before TACE and at 3-10 days after TACE. Choline-to-lipid (Cho/Lip), glucogen/glucose-to-lipid (Glu/Lip), and glytamine/glutamate-to-lipid (Glx/Lip) ratios were measured and analyzed statistically.
Results: The Cho/Lip, Glu/Lip, and Glx/Lip ratios were 0.21 +/- 0.08, 0.11 +/- 0.05, 0.28 +/- 0.10 before TACE, respectively, and were 0.10 +/- 0.08, 0.07 +/- 0.07, 0.18 +/- 0.12 after TACE, respectively, with significant differences (P < 0.05).
Conclusions: Using MRS can evaluate the early metabolic responses of HCC to TACE.
Source: PubMed